Efficacy and Safety of Long-Acting Glucagon-Like Peptide-1 Receptor Agonists Compared with Exenatide Twice Daily and Sitagliptin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
2017 ◽
Vol 27
(12)
◽
pp. 1081-1088
◽
2010 ◽
Vol 71
(4)
◽
pp. 211-238
◽
2016 ◽
Vol 19
(2)
◽
pp. 228-238
◽